A Study to Learn How Safe the Study Treatment BAY2701250 is, How it Affects the Body and How it Moves Into, Through and Out of the Body in Healthy Male Participants When a Single Amount is Given as an Injection Into the Vein (Intravenous Infusion) or Under the Skin (Subcutaneous Injection)

NCT06048120 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Hypertension Due to Left Heart Disease

Interventions

DRUG: BAY2701250 IV
DRUG: Placebo IV
DRUG: BAY2701250 SC
DRUG: Placebo SC

Sponsor

Bayer